Guest article: Corinne Hinlopen, Global Health Advocate and Policy Researcher at Wemos Foundation In spite of ambitions to emerge stronger from the COVID-19 crisis, Europe’s €672.5 billion COVID Recovery Package is intended for national recovery plans only. But in an...
Learning lessons from the COVID-19 pandemic, EPHA joins a range of health organisations (representing patients, healthcare professionals and medical societies, industry, public institutes and broader health advocacy groups) to call on the EU Council to extend the...
Why are we vaccine hesitant in a pandemic? Tools to boost confidence in vaccines 22 April 2021 15:00 - 16:00 CET Online The process of developing COVID-19 vaccines has highlighted not only the undisputed importance of these products in safeguarding public health...
Why and how should we prioritize marginalized communities in the rollout of COVID-19 vaccines in Europe? 25 March 2021 16:00 - 17:00 CET Webinar Public health means protection of the population as a whole and health for all. It is not only a question of...
After COVID-19, what’s next for EU medicines policies? 9 March 2021 16:00 - 17:00 CET Online Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry...
